Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 28 | $7,384,340 |
| Sells | 20 | $2,594,366 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 20 Nov 2024 16:20 | ACRS | Aclaris Therapeutics Inc | MEHRA ANAND | Director | 19 Nov 2024 | Purchase | 666,666 | 2.25 | 1,499,998 | D |
| 05 Aug 2024 15:57 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 05 Aug 2024 | Purchase | 206,025 | 1.2443 | 256,357 | I |
| 05 Aug 2024 15:57 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 02 Aug 2024 | Purchase | 167,544 | 1.2916 | 216,400 | I |
| 31 Jul 2024 16:10 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 31 Jul 2024 | Purchase | 100,000 | 1.3264 | 132,640 | I |
| 31 Jul 2024 16:10 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 30 Jul 2024 | Purchase | 173,730 | 1.303 | 226,370 | I |
| 22 Jul 2024 16:03 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 22 Jul 2024 | Purchase | 17,716 | 1.3297 | 23,557 | I |
| 22 Jul 2024 16:03 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 19 Jul 2024 | Purchase | 6,689 | 1.3 | 8,696 | I |
| 22 Jul 2024 16:03 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 18 Jul 2024 | Purchase | 130,317 | 1.3011 | 169,555 | I |
| 05 Jul 2024 14:46 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 05 Jul 2024 | Purchase | 123,017 | 1.1489 | 141,334 | I |
| 05 Jul 2024 14:46 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 02 Jul 2024 | Purchase | 86,092 | 1.144 | 98,489 | I |
| 05 Jul 2024 14:46 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 03 Jul 2024 | Purchase | 143,288 | 1.159 | 166,071 | I |
| 01 Jul 2024 13:39 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 01 Jul 2024 | Purchase | 107,434 | 1.1373 | 122,185 | I |
| 01 Jul 2024 13:39 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 28 Jun 2024 | Purchase | 801,000 | 1.1193 | 896,559 | I |
| 01 Jul 2024 13:39 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 28 Jun 2024 | Purchase | 400,000 | 1.13 | 452,000 | I |
| 01 Jul 2024 13:39 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 27 Jun 2024 | Purchase | 235,000 | 1.1546 | 271,331 | I |
| 18 Jun 2024 16:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 18 Jun 2024 | Purchase | 50,000 | 1.1301 | 56,505 | I |
| 18 Jun 2024 16:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 17 Jun 2024 | Purchase | 150,000 | 1.13 | 169,500 | I |
| 18 Jun 2024 16:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 14 Jun 2024 | Purchase | 345,000 | 1.1658 | 402,201 | I |
| 13 Jun 2024 18:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 13 Jun 2024 | Purchase | 500,000 | 1.15 | 575,000 | I |
| 13 Jun 2024 18:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 13 Jun 2024 | Purchase | 28,621 | 1.1445 | 32,757 | I |
| 13 Jun 2024 18:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 12 Jun 2024 | Purchase | 82,579 | 1.14 | 94,140 | I |
| 13 Jun 2024 18:04 | ACRS | Aclaris Therapeutics Inc | LEONARD BRADEN MICHAEL | 10% | 11 Jun 2024 | Purchase | 1,000,000 | 1.08 | 1,080,000 | I |
| 05 Mar 2024 16:58 | ACRS | Aclaris Therapeutics Inc | POWELL ANDREW KENNETH WILLIAM | Director | 04 Mar 2024 | Purchase | 6,000 | 1.25 | 7,500 | D |
| 05 Mar 2024 16:58 | ACRS | Aclaris Therapeutics Inc | POWELL ANDREW KENNETH WILLIAM | Director | 01 Mar 2024 | Purchase | 8,500 | 1.23 | 10,455 | D |
| 25 Oct 2023 16:28 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 23 Oct 2023 | Sale | 6,000 | 5.0767 | 30,460 | D |
| 07 Sep 2023 16:16 | ACRS | Aclaris Therapeutics Inc | BALTHASER KEVIN | Chief Financial Officer | 06 Sep 2023 | Purchase | 9,490 | 7.9 | 74,971 | D |
| 28 Aug 2023 16:39 | ACRS | Aclaris Therapeutics Inc | LOEROP JAMES | Chief Business Officer | 28 Aug 2023 | Purchase | 14,705 | 6.7976 | 99,959 | D |
| 22 Aug 2023 16:31 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 21 Aug 2023 | Sale | 6,000 | 7.3158 | 43,895 | D |
| 22 Jun 2023 16:30 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 20 Jun 2023 | Sale | 6,000 | 10.2771 | 61,663 | D |
| 17 Mar 2023 17:03 | ACRS | Aclaris Therapeutics Inc | MANION DOUGLAS J. | Pres and CEO | 17 Mar 2023 | Purchase | 6,300 | 7.8623 | 49,532 | D |
| 09 Mar 2023 17:56 | ACRS | Aclaris Therapeutics Inc | MANION DOUGLAS J. | Pres and CEO | 09 Mar 2023 | Purchase | 6,500 | 7.735 | 50,278 | D |
| 03 Mar 2023 20:37 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 03 Mar 2023 | Sale | 30,240 | 12.6346 | 382,070 | D |
| 03 Mar 2023 20:37 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 02 Mar 2023 | Sale | 29,000 | 12.3651 | 358,588 | D |
| 03 Mar 2023 20:12 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 03 Mar 2023 | Sale | 16,037 | 12.6342 | 202,615 | D |
| 03 Mar 2023 20:12 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 02 Mar 2023 | Sale | 14,800 | 12.3665 | 183,024 | D |
| 03 Mar 2023 20:09 | ACRS | Aclaris Therapeutics Inc | BALTHASER KEVIN | Chief Financial Officer | 03 Mar 2023 | Sale | 894 | 12.6281 | 11,290 | D |
| 03 Mar 2023 20:09 | ACRS | Aclaris Therapeutics Inc | BALTHASER KEVIN | Chief Financial Officer | 02 Mar 2023 | Sale | 1,000 | 12.289 | 12,289 | D |
| 17 Feb 2023 16:34 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 15 Feb 2023 | Sale | 5,000 | 13.0621 | 65,310 | D |
| 10 Feb 2023 16:55 | ACRS | Aclaris Therapeutics Inc | LOEROP JAMES | Chief Business Officer | 08 Feb 2023 | Sale | 4,267 | 13.8909 | 59,272 | D |
| 03 Feb 2023 17:09 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 02 Feb 2023 | Sale | 200 | 17.535 | 3,507 | D |
| 03 Feb 2023 17:09 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 02 Feb 2023 | Sale | 3,121 | 16.8827 | 52,691 | D |
| 03 Feb 2023 17:09 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 02 Feb 2023 | Sale | 600 | 15.5533 | 9,332 | D |
| 03 Feb 2023 17:09 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 02 Feb 2023 | Sale | 1,079 | 14.5671 | 15,718 | D |
| 03 Feb 2023 17:09 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 01 Feb 2023 | Sale | 25,000 | 16.747 | 418,675 | D |
| 04 Jan 2023 18:20 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 04 Jan 2023 | Sale | 15,000 | 14.8895 | 223,342 | D |
| 04 Jan 2023 18:20 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 03 Jan 2023 | Sale | 1,618 | 16.1594 | 26,146 | D |
| 04 Jan 2023 18:20 | ACRS | Aclaris Therapeutics Inc | WALKER NEAL | Director | 03 Jan 2023 | Sale | 23,382 | 15.1855 | 355,067 | D |
| 16 Dec 2022 16:57 | ACRS | Aclaris Therapeutics Inc | MONAHAN JOSEPH | Chief Scientific Officer | 15 Dec 2022 | Sale | 5,000 | 15.8823 | 79,412 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)